605266.SH
健之佳
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 16.46
−0.42%Year over year
Reported trailing growth
- Revenue
- -5.9%
- EBITDA
- —
- EBIT
- +36.8%
- EPS
- +40.1%
- Free cash flow
- +198.0%
- Operating cash flow
- +95.9%
Forward estimates
Based on analyst estimates
- Revenue
- +2.0%
- EBITDA
- +48.7%
- EPS
- +116.8%
Three-year CAGR
- Revenue
- +5.9%
- EBITDA
- -9.5%
- EBIT
- -22.2%
- Net income
- -26.6%
- EPS
- -30.4%
- Free cash flow
- +35.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026